About TRIO-US Central Administration
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at TRIO-US Central Administration
During the past decade, TRIO-US Central Administration conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 9 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "TRIO-US Central Administration"
#1 collaborator was "Medivation, Inc." with 4 trials as a collaborator and "Myriad Genetic Laboratories, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at TRIO-US Central Administration
According to Clinical.Site data, the most researched conditions in "TRIO-US Central Administration" are
"Breast Neoplasms" (3 trials), "BRCA 1 Gene Mutation" (2 trials), "BRCA 2 Gene Mutation" (2 trials), "Breast Cancer" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "TRIO-US Central Administration" in a lesser frequency.
Clinical Trials Intervention Types at TRIO-US Central Administration
Most popular intervention types in "TRIO-US Central Administration" are "Drug" (9 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "PF-05212384" (2 trials), "Talazoparib" (2 trials), "talazoparib" (2 trials), "Alclometasone cream" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at TRIO-US Central Administration
The vast majority of trials in "TRIO-US Central Administration" are
7 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at TRIO-US Central Administration
Currently, there are NaN active trials in "TRIO-US Central Administration".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in TRIO-US Central Administration,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in TRIO-US Central Administration, 2 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".